“In science and medicine, information is constantly changing and may become out-of-date as new data becomes available. All articles, videos and interviews were up to date at the time of publication. If you are a patient, this information is not intended to replace advice you may be given by your medical team. If using our Accessibility Tool note that it uses Google Translate which may not always accurately represent the original text.”
This section is designed for Health Care Professionals and covers the latest information available for the treatment and management of SLL and CLL. We aim to keep this area up to date with developments in CLL research.
In 2025, the British Society of Haematology published new guidelines for the treatment of SLL/CLL. The full guidelines are available for review here.
Links to previous educational session videos can be found lower down this page on the right.
Contributors include: Dr Dima El-Sharkawi, Professor George Follows’ Dr David Lowe, Dr Renata Walewska and CLL Trustee John Greensmyth.
CLL – Diagnostics, Prognostics and Monitoring of CLL. UK CLL Forum 2026 week1 part1
Infection and CLL (Chronic Lymphocytic Leukaemia) .UK CLL Forum Webinar 2026 week1 part2
CLL- First line treatment options Dr Helen Marr, UK CLL Forum Webinar 2026 week2 part1
What matters most to patients? UK CLL Forum Webinar 2026 week2 part2
CLL – Treatment options for previously treated patients . UK CLL Forum Webinar 2026 week3 part1
Richter’s transformation , Dr Toby Eyre, UK CLL Forum Webinar 2026 week3 part2
UK CLL Forum
Cll Support is the official charity partner of the UK CLL Forum. Follow this link to their website.
UK CLL Forum2025 British Society for Haematology Guidelines
The latest British Society for Haematology guidelines for the treatment of chronic lymphocytic leukaemia published 9 October 2025.
GuidelinesIntroduction to GP Guide
CLL Support General Practioner Guide
Information for patients
Order our patient information booklet and leaflets here
BSH Good practise paper for Richter's Transformation
A recently published paper from the British Society of Haematologists can be found here
British Society of Haematologists paperDiagnosis and prognosis in CLL/SLL
The webinar was chaired by Prof. Paolo Ghia and featured a presentation on CLL diagnosis and prognostic markers, a case study presentation on a patient with accelerated CLL, a debate on clinically relevant biomarkers, and an audience Q&A session. The other panel members were Prof. Anna Schuh and Dr Davide Rossi. Webinar available here.
Note: this is for HCPs only and registration is required.
Predicting Atrial Fibrillation Risk in Patients with CLL
A recent paper given by Dr. AnnLiu at the 2025 ASH conference used AI to develop a risk score for predicting atrial fibrillation in treatment-naive CLL patients. Conclusion: Patients who are categorized as at high risk of atrial fibrillation should be closely monitored. However, the development of atrial fibrillation does not affect overall survival or progression-free survival. You can find the full paper here.
UK CLL Forum and CLL Support 2025 education sessions
Relapsed CLL; Shared decision making; CLL Refresher with gems from ASH4; First line CLL therapy; Trials in CLL; Virtual MDT
UK CLL Forum and CLL Support 2025 Education SessionsUK CLL Forum and CLL Support 2024 Education Sessions
A CLL refresher with gems from ASH23. The complete training course.
UK CLL Forum and CLL Support 2024 Education SessionsUK CLL Forum and CLL Support 2023 Education Sessions
CLL basic facts; Clinical Trials in the UK; What’s new in CLL; Immunosuppression and risk of infection; Managing autoimmune complications; Richter’s transformation
UK CLL Forum and CLL Support 2023 Education SessionsUK CLL Forum and CLL Support 2022 Education Sessions
Complications not related to CLL Therapy; CLL – Laboratory work-up and prognostic biology; CLL First line therapy; CLL relapsed – Choices; Managing complications; CLL and genomica – a new standard?
UK CLL Forum and CLL Support 2022 Education SessionsTrusted Information Creator
